Development of Microelectrode Arrays Dr. Peter D. Jones Group Leader Biomedical Micro and Nano Engineering +49 7121 51530-800 E-Mail anzeigen Microelectrode Arrays (MEAs) are instrumental in electroph
Degradation and Remodeling of Implant Materials Dr. Julia Marzi Group Leader Biophotonics & Spectroscopy +49 7121 07121 51530-78 E-Mail anzeigen Dr. Hanna Hartmann Head of Biomedicine & Material Scien
Mechanisms of CNS Diseases Dr. Frank Weise Group Leader Molecular- und Neurobiology +49 7121 51530-56 E-Mail anzeigen Prof. Dr. Hansjürgen Volkmer Head of Pharma & Biotech +49 7121 51530-44 E-Mail anz
Biomarker Detection Dr. Martin Kriebel Molecular and Neurobiology +49 7121 51530-810 E-Mail anzeigen AI-supported diagnosis of tumor-associated drug resistance Late stage cancers have a high tendency
Your career opportunity Our employees are the heart of the NMI. With their unique skills, knowledge and experience, they contribute significantly to the success of the institute. Teamwork is a top pri
Development of Microelectrode Arrays Dr. Peter D. Jones Group Leader Biomedical Micro and Nano Engineering +49 7121 51530-800 E-Mail anzeigen Microelectrode Arrays (MEAs) are instrumental in electroph
How can animal testing be reduced, how can the suffering of animals be alleviated? NMI scientist Peter Loskill talked about that with several other experts in the German Bundestag. How can animal test
CAR-T cell therapies in the individualized treatment of patients with acute leukemias and lymphomas are a milestone in cancer therapy. With two marketable products, a breakthrough has been made in the
Multi-Pathogenic Serology Determining antibody status post-infection or post-vaccination Serological immmunoassays are essential tools across multiple research disciplines: they are used to investigat
In Process Control of ATMPs Dr. Julia Marzi Group Leader Biophotonics & Spectroscopy +49 7121 07121 51530-78 E-Mail anzeigen Identification of process-relevant parameters for monitoring ATMPs ATMPs su